What is Brian Matthys's NPI number?

Brian Matthys's National Provider Identifier (NPI) is 1982631172, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Brian Matthys's specialty?

Brian Matthys is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Brian Matthys located?

Brian Matthys's practice location on file with NPPES is 1805 Nw Platte Rd, Riverside, MO 64150-9601.

What is Brian Matthys's phone number?

The practice phone number listed in the NPPES registry for Brian Matthys is (816) 472-0400.

Does Brian Matthys accept Medicare?

Brian Matthys is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Brian Matthys's NPI active?

Yes — Brian Matthys's NPI (1982631172) is active in the NPPES registry as of the last update on 2014-02-25.

IndividualActiveAccepts Medicare

Brian Matthys, D.O.

NPI 1982631172 · Dermatology Physician · Riverside, MO

Brian Matthys, D.O. is a Dermatology Physician provider in Riverside, MO (NPI 1982631172).

Provider details

NPI number: 1982631172
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: D.O.
Sex: Male
Sole proprietor: No
License: 2000152165 (MO)

Practice location

1805 Nw Platte Rd

Suite 120

Riverside, MO 64150-9601

Phone: (816) 472-0400

Street-level locationGet directions

More MO providers

Mailing address

9701 Sagamore Rd

Leawood, KS 66206-2313

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2000152165 (MO)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(76/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,968 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	491	$85
Destruction of Precancer Skin Growth, 2-14 Growths17003	268	$6
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	197	$121
Destruction of Precancer Skin Growth, 1 Growth17000	186	$51
Biopsy of Related Skin Growth, First Growth11102	157	$86
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Cephalexin	124	101
Triamcinolone Acetonide	117	77
Clobetasol Propionate	103	55
Hydrocortisone	79	71
Ciclopirox Olaminebrand: Ciclopirox	53	31
Doxycycline Hyclate	45	22
Fluorouracil	35	34
Terbinafine Hcl	27

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,182 across 66 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-06-26
Last updated: 2014-02-25

Frequently asked questions

What is Brian Matthys's NPI number?: Brian Matthys's National Provider Identifier (NPI) is 1982631172, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Brian Matthys's specialty?: Brian Matthys is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Brian Matthys located?: Brian Matthys's practice location on file with NPPES is 1805 Nw Platte Rd, Riverside, MO 64150-9601.
What is Brian Matthys's phone number?: The practice phone number listed in the NPPES registry for Brian Matthys is (816) 472-0400.
Does Brian Matthys accept Medicare?: Brian Matthys is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Brian Matthys's NPI active?: Yes — Brian Matthys's NPI (1982631172) is active in the NPPES registry as of the last update on 2014-02-25.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	491	$85
Destruction of Precancer Skin Growth, 2-14 Growths17003	268	$6
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	197	$121
Destruction of Precancer Skin Growth, 1 Growth17000	186	$51
Biopsy of Related Skin Growth, First Growth11102	157	$86
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Cephalexin

124

101

Triamcinolone Acetonide

117

Clobetasol Propionate

103

Hydrocortisone

Ciclopirox Olaminebrand: Ciclopirox

Doxycycline Hyclate

Fluorouracil

Terbinafine Hcl

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,182 across 66 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments